MB, Levis & Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79K | Hold |
32
| – | – | ﹤0.01% | 236 |
|
|
2025
Q1 | $2.19K | Hold |
32
| – | – | ﹤0.01% | 250 |
|
|
2024
Q4 | $2.49K | Hold |
32
| – | – | ﹤0.01% | 253 |
|
|
2024
Q3 | $2.15K | Hold |
32
| – | – | ﹤0.01% | 258 |
|
|
2024
Q2 | $3.63K | Hold |
32
| – | – | ﹤0.01% | 232 |
|
|
2024
Q1 | $4.44K | Hold |
32
| – | – | ﹤0.01% | 224 |
|
|
2023
Q4 | $3.97K | Hold |
32
| – | – | ﹤0.01% | 223 |
|
|
2023
Q3 | $2.99K | Hold |
32
| – | – | ﹤0.01% | 233 |
|
|
2023
Q2 | $4.11K | Hold |
32
| – | – | ﹤0.01% | 227 |
|
|
2023
Q1 | $3.72K | Hold |
32
| – | – | ﹤0.01% | 231 |
|
|
2022
Q4 | $3.62K | Buy |
+32
| New | +$3.62K | ﹤0.01% | 214 |
|